
Dual GLP-1/GIP receptor agonist for metabolic research
This product is coming soon. Join the waitlist to be notified when it's available.
These products are intended for laboratory research use only and are not for human consumption. Not for use in food, drug, household, or cosmetic applications. All research should be conducted in accordance with applicable safety guidelines and regulations.
Tirzepatide is a synthetic dual agonist that activates both GLP-1 and GIP receptors through a single peptide molecule. This dual-incretin mechanism has generated significant scientific interest for its multi-pathway approach to metabolic regulation research.
Phase 3 SURPASS trials demonstrated tirzepatide's differentiated receptor pharmacology, with researchers noting additive effects from combined GLP-1 and GIP pathway co-activation in metabolic studies.
Store in refrigerator at 4°C, tightly sealed, away from heat, light and moisture.. Keep frozen until ready to reconstitute.
Use sterile water for injection. Allow to reach room temperature before reconstitution.